Pfizer Inc. is recalling 89,700 vials of Vancomycin Hydrochloride for Injection, USP (1.5 g/vial) because glass particulate matter was detected in the injectable medication. This sterile powder, distributed by Hospira, Inc., is intended for intravenous use in clinical settings. While no incidents or injuries have been reported to date, the presence of glass in an injectable drug poses serious safety risks to patients.
Injecting a drug containing glass particles can cause local irritation, swelling, and inflammation. More severe risks include the formation of blood clots, blockages in blood vessels, and damage to vital organs if the particles travel through the circulatory system.
Distributed by Hospira, Inc.; 10 vials per carton.
Image 1 - Vancomycin Hydrochloride for Injection, USP, For intravenous use, 1.5 g Single-dose Fliptop Vial, Sterile Powder
Image 2 - Vancomycin Hydrochloride for Injection, USP, For intravenous use, 1.5 g Single-dose Fliptop Vial, Sterile Powder
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.